OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.48 USD
-0.11 (-6.92%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.51 +0.03 (2.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 96 | 153 | 135 | 72 | 85 |
Receivables | 123 | 127 | 260 | 286 | 135 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 66 | 74 | 87 | 132 | 53 |
Other Current Assets | 25 | 40 | 342 | 32 | 51 |
Total Current Assets | 309 | 395 | 823 | 523 | 324 |
Net Property & Equipment | 75 | 83 | 80 | 141 | 127 |
Investments & Advances | 16 | 28 | 11 | 16 | 21 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,339 | 1,419 | 842 | 1,156 | 1,201 |
Deposits & Other Assets | 204 | 204 | 600 | 600 | 597 |
Total Assets | 2,012 | 2,167 | 2,400 | 2,473 | 2,309 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 70 | 67 | 276 | 101 | 63 |
Current Portion Long-Term Debt | 27 | 37 | 0 | 25 | 10 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 90 | 98 | 0 | 241 | 165 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 43 | 0 | 0 |
Total Current Liabilities | 200 | 213 | 330 | 375 | 249 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 127 | 126 | 148 | 137 | 119 |
Convertible Debt | 214 | 210 | 188 | 222 | 211 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 27 | 27 | 15 | 37 | 88 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 622 | 606 | 715 | 802 | 695 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 8 | 8 | 7 | 7 | 7 |
Capital Surplus | 3,433 | 3,422 | 3,222 | 3,153 | 3,143 |
Retained Earnings | -2,012 | -1,823 | -1,512 | -1,482 | -1,511 |
Other Equity | -38 | -43 | -31 | -4 | -22 |
Treasury Stock | 2 | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | 1,389 | 1,562 | 1,685 | 1,672 | 1,615 |
Total Liabilities & Shareholder's Equity | 2,012 | 2,167 | 2,400 | 2,473 | 2,309 |
Total Common Equity | 1,389 | 1,562 | 1,685 | 1,672 | 1,615 |
Shares Outstanding | 773.20 | 772.60 | 681.30 | 670.00 | 665.60 |
Book Value Per Share | 1.80 | 2.02 | 2.47 | 2.49 | 2.43 |
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 41 | 76 | 96 | 139 | 108 |
Receivables | 105 | 111 | 123 | 117 | 211 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 60 | 59 | 66 | 69 | 74 |
Other Current Assets | 152 | 145 | 25 | 32 | 41 |
Total Current Assets | 358 | 391 | 309 | 357 | 434 |
Net Property & Equipment | 67 | 64 | 75 | 78 | 79 |
Investments & Advances | 101 | 41 | 16 | 19 | 28 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,189 | 1,211 | 1,339 | 1,353 | 1,380 |
Deposits & Other Assets | 203 | 204 | 204 | 204 | 204 |
Total Assets | 1,980 | 1,974 | 2,012 | 2,057 | 2,159 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 23 | 0 | 30 | 29 |
Accounts Payable | 82 | 71 | 70 | 67 | 88 |
Current Portion Long-Term Debt | 22 | 0 | 27 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 95 | 89 | 90 | 92 | 99 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 9 | 10 | 0 | 0 | 0 |
Total Current Liabilities | 220 | 204 | 200 | 201 | 226 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 119 | 122 | 127 | 138 | 133 |
Convertible Debt | 176 | 323 | 214 | 213 | 212 |
Long-Term Debt | 0 | 21 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 20 | 27 | 26 | 27 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 585 | 721 | 622 | 612 | 624 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 7 | 7 | 8 | 8 | 8 |
Capital Surplus | 3,540 | 3,386 | 3,433 | 3,430 | 3,427 |
Retained Earnings | -2,104 | -2,094 | -2,012 | -1,945 | -1,861 |
Other Equity | -47 | -45 | -38 | -47 | -37 |
Treasury Stock | 2 | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | 1,395 | 1,253 | 1,389 | 1,445 | 1,535 |
Total Liabilities & Shareholder's Equity | 1,980 | 1,974 | 2,012 | 2,057 | 2,159 |
Total Common Equity | 1,395 | 1,253 | 1,389 | 1,445 | 1,535 |
Shares Outstanding | 696.90 | 696.90 | 773.20 | 773.00 | 773.00 |
Book Value Per Share | 2.00 | 1.80 | 1.80 | 1.87 | 1.99 |